Ultrahuman has partnered with Click Therapeutics to develop a Migraine PowerPlug, set for early 2026. The feature uses biomarker analytics and CT-132, an FDA-authorized digital therapy, to offer real-time migraine insights.

Designed with women’s health in focus, it tracks factors like sleep quality, HRV, and stress. These metrics help identify patterns that contribute to migraines, offering personalized lifestyle recommendations for users.

The tool builds on Ultrahuman’s prior efforts in women's health, including cycle-tracking features. A pilot phase will precede the full rollout across the U.S., Canada, EU, India, and Australia. Experts say digital therapeutics could reshape chronic condition management.